Clinical Trial Update: Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients [NA]

View source ↗

Summary

A University of Chicago-sponsored study is evaluating measurable residual disease in multiple myeloma patients, with the trial currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Chicago | Conditions: Multiple Myeloma | NA | Status: ACTIVE_NOT_RECRUITING